COMEX silver fell 1% in the day, Comex silver fell 1% in the day, and it is now reported at $32.63 per ounce.Black futures fell rapidly in the short term, with the main contracts of hot coil and coking coal falling by more than 1%, and the main contracts of coke, thread and iron ore falling by nearly 1%.Trade union representative: STELLANTIS told us that the output of Italy in 2025 will be similar to this year, about 500,000 vehicles.
Analyst: The interest rate of the European Central Bank will be pushed to the low end of the neutral range. Marchel Alexandrovich, an economist at Saltmarsh Economics, said that the European Central Bank cut interest rates by 25 basis points again, which is the fourth time in this easing cycle. The monetary policy statement reiterated that the Committee would not commit to a specific interest rate path in advance. However, the new forecast shows that the core inflation rate is 1.9% in 2026 and 2027, which indicates that interest rates may continue to push to the low end of the neutral range.South Korea's finance ministers and Japan's finance ministers held an online meeting, and the two sides reiterated the importance of the partnership between the two countries.ECB: Most indicators show that the inflation rate will stabilize at 2%.
The Korea Composite Index closed up 1.60%.Shenzhen Energy Investment established a new energy development company, and the enterprise search APP showed that recently, Shenneng (Zhuolu) New Energy Development Co., Ltd. was established, with Li Xuedong as the legal representative and a registered capital of 2 million yuan. Its business scope includes: solar power generation technical services; Technical services for wind power generation; Research and development of wind farm related systems; Energy storage technology services, etc. Enterprise survey shows that the company is indirectly wholly-owned by Shenzhen Energy.The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14